Field testing for CBD will focus on the relevance and usability of six EPAs, which have been developed by the Medical Oncology specialty committee.
EPAs in Foundations of Discipline stage (PGY 4)
- Providing initial consultations (uncomplicated patients)
- Providing assessment and management for ongoing care (uncomplicated patients)
- Discussing serious news
EPAs in Core of Discipline stage (PGY 5)
- Perform initial consultations (full range of patients)
- Providing assessment and management for ongoing care (full range of patients)
- Transitioning care away from disease modifying therapies
We have designed new observations tools to accompany EPAs. The tests will look at the functionality of these new tools. We’ll hear directly from teachers and learners and determine if the tools can be completed without significantly interrupting clinical workflows, and if they provide learners with useful feedback.
For field testing purposes, the new (EPA specific) Royal College observation tools are accessible in paper-format and via the newly launched MAINPORT ePortfolio (Residency Prototype 1). Faculties can choose to use the Royal College observation tools to evaluate the EPA (in either paper or electronic format), or they can choose to use their own local tools.
Field test process
As mentioned, the field tests are completely voluntary. We’ve reached out to the Postgraduate (PG) Deans and invited them to work with their Medical Oncology Program Directors (PD) to determine if they’d like to participate in field testing.
Interested PG Deans and PDs will work together to
- choose the EPAs they’d like to test,
- determine which observation tool they’d like to use to evaluate the EPA,
- determine how they will access their chosen observation tool, and
- invite teachers and learners in Medical Oncology to participate in field testing.
Teachers and learners invited to participate in voluntary field tests
Once the logistics of the field tests have been determined, the PG Deans will share a letter of information with all teachers and learners in the first year of Medical Oncology, inviting them to participate in voluntary field testing activities.
Teachers and learners who choose to participate will work together to set-up their own observation schedule and will take part in EPA observation encounters at their own pace. Following an observation encounter, both teachers and learners will complete a short survey to assess the validity of the EPA, the observation tool used and the process overall.
Participation in EPA-based observations will not replace the traditional Medical Oncology observations at this time. Existing assessment activities, such as In-Training Evaluation Reports (ITERS) and Final-In Training Evaluation Reports (FITERS), will continue for Medical Oncology learners regardless of their involvement in field testing. By participating in field testing activities, learners and teachers have the opportunity to contribute their valuable input and guidance to the CBD assessment process.
Participation in field testing will not affect learner progression
The privacy and security of resident data is of upmost importance to the Royal College. All data gathered by the Royal College during field testing will be de-identified. Paper forms will not be sent to the Royal College, and when reviewing the ePortfolio content, it will be impossible to connect results back to a specific teacher or learner.
Furthermore, the Royal College will not use the completed observation forms to assess learner performance in any way. In fact, we’ll only be able to access forms completed using the MAINPORT ePortfolio (Residency Prototype 1) – we will never see the paper-based or local university forms. Most importantly, all data (including the survey data) will be purged within one year of completion of the field test. Data gathered will be used by the Royal College for CBD improvement purposes only.
Let us know what you think of our field testing process by emailing firstname.lastname@example.org For more information about CBD, please visit www.royalcollege.ca/cbd or email email@example.com.